Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody cancer therapeutics
ORION CORPORATION PRESS RELEASE 30 JANUARY 2025 at 16.00 EET Orion and Invenra announce discovery service and commercial ...
Health Rounds: Drug cocktail helps keep liver cancer at bay
Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly doubled the amount of time ...
devdiscourse7d
Revolutionizing Cancer and Bone Treatments
Recent studies highlight breakthroughs in medical treatments. A novel monoclonal antibody cocktail has shown promise in ...
PharmiWeb20h
Antibody Therapy Market to Surge, Expected to Reach USD 824 Billion by 2033 at a 13.4% of CAGR
Antibody Therapy MarketThe global antibody therapy market is on a strong growth trajectory, projected to expand at a CAGR of ...
WebMD7d
FDA Approves New Treatment for Advanced Breast Cancer
The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the ...
Medscape1d
Novel Anti-CTGF Antibody Plus Chemotherapy Shows No Survival Benefit in Locally Advanced Pancreatic Cancer
Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...
Leap scraps late-stage plans for gastric cancer therapy after mid-stage setback
Leap Therapeutics (LPTX) lost 63% after announcing it will not run a Phase 3 trial for its lead asset sirexatamab in gastric ...
Pharm Exec2d
CStone and SteinCares Partner to Market and Commercialize Cancer Medication in Latin America
CStone, the drug’s developer, previously announced similar deals with various pharmaceutical companies to expand sugemalimab ...
Biologics Market Research Report 2024-2030: Technological Innovations in Monoclonal Antibodies and Gene Therapies Fueling Developments and Growth
The "Biologics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global ...
Antibody Drug Conjugates Market Size is Expected to Reach USD 25.38 Billion by 2033, Growing at a CAGR of 8.84%: Straits Research
The global antibody drug conjugates market size was valued at USD 11.84 billion in 2024 and is projected to reach from USD 12 ...
Invenra and Orion Announce Discovery Service and Commercial License Agreement to Develop Innovative Bispecific Antibody Cancer Therapeutics
Orion Corporation ("Orion"), a globally operating pharmaceutical company, and Invenra Inc., an innovative biotechnology company with proprietary technologies for discovering novel therapeutics, today ...